1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Biocompatibility of mannan nanogel-safe interaction with plasma proteins
(
- Contribution to journal › Article
-
Mark
Polystyrene nanoparticles affecting blood coagulation.
(
- Contribution to journal › Article
- 2011
-
Mark
Structural Changes in Apolipoproteins Bound to Nanoparticles
(
- Contribution to journal › Article
- 2010
-
Mark
ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATION
2010) 78th Congress of the European-Atherosclerosis-Society In Atherosclerosis Supplements 11(2). p.233-233(
- Contribution to journal › Published meeting abstract
-
Mark
The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.
(
- Contribution to journal › Article
-
Mark
Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.
(
- Contribution to journal › Article
-
Mark
Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans.
(
- Contribution to journal › Article
- 2009
-
Mark
Anticoagulant Properties Of Apolipoprotein A-I And Phospholipid Transfer Protein
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.138-138(
- Contribution to journal › Published meeting abstract
-
Mark
Anionic Phospholipids Lose their Procoagulant Properties when Incorporated into High-Density Lipoproteins.
(
- Contribution to journal › Article
-
Mark
Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.
(
- Contribution to journal › Article